 | • レポートコード：QYR2104Z4085 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・神経芽細胞腫治療の市場動向 ・企業の競争状況、市場シェア ・神経芽細胞腫治療の種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他） ・神経芽細胞腫治療の用途別市場規模（病院、診療所、その他） ・神経芽細胞腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・神経芽細胞腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経芽細胞腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経芽細胞腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経芽細胞腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Seattle Children’s、CureSearch、Texas Children’s、NANT） ・結論 |
Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child.
Market Analysis and Insights: Global Neuroblastoma Treatment Market
The global Neuroblastoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroblastoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroblastoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroblastoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroblastoma Treatment market.
Global Neuroblastoma Treatment Scope and Market Size
Neuroblastoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroblastoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Combination Chemotherapy
Monoclonal Antibody Therapy
Vaccine Therapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Seattle Children’s
CureSearch
Texas Children’s
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Combination Chemotherapy
1.2.3 Monoclonal Antibody Therapy
1.2.4 Vaccine Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neuroblastoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroblastoma Treatment Market Perspective (2016-2027)
2.2 Neuroblastoma Treatment Growth Trends by Regions
2.2.1 Neuroblastoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuroblastoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Neuroblastoma Treatment Industry Dynamic
2.3.1 Neuroblastoma Treatment Market Trends
2.3.2 Neuroblastoma Treatment Market Drivers
2.3.3 Neuroblastoma Treatment Market Challenges
2.3.4 Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Neuroblastoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroblastoma Treatment Revenue
3.4 Global Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2020
3.5 Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027)
5 Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neuroblastoma Treatment Market Size (2016-2027)
6.2 North America Neuroblastoma Treatment Market Size by Type
6.2.1 North America Neuroblastoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Neuroblastoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Neuroblastoma Treatment Market Size by Type (2016-2027)
6.3 North America Neuroblastoma Treatment Market Size by Application
6.3.1 North America Neuroblastoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Neuroblastoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Neuroblastoma Treatment Market Size by Application (2016-2027)
6.4 North America Neuroblastoma Treatment Market Size by Country
6.4.1 North America Neuroblastoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Neuroblastoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size (2016-2027)
7.2 Europe Neuroblastoma Treatment Market Size by Type
7.2.1 Europe Neuroblastoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Neuroblastoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Neuroblastoma Treatment Market Size by Type (2016-2027)
7.3 Europe Neuroblastoma Treatment Market Size by Application
7.3.1 Europe Neuroblastoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Neuroblastoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Neuroblastoma Treatment Market Size by Application (2016-2027)
7.4 Europe Neuroblastoma Treatment Market Size by Country
7.4.1 Europe Neuroblastoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Neuroblastoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Neuroblastoma Treatment Market Size by Type
8.2.1 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Application
8.3.1 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuroblastoma Treatment Market Size by Region
8.4.1 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuroblastoma Treatment Market Size (2016-2027)
9.2 Latin America Neuroblastoma Treatment Market Size by Type
9.2.1 Latin America Neuroblastoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Neuroblastoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Neuroblastoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Neuroblastoma Treatment Market Size by Application
9.3.1 Latin America Neuroblastoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Neuroblastoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Neuroblastoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Neuroblastoma Treatment Market Size by Country
9.4.1 Latin America Neuroblastoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Neuroblastoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type
10.2.1 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application
10.3.1 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuroblastoma Treatment Market Size by Country
10.4.1 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Details
11.1.2 Seattle Children’s Business Overview
11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction
11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2016-2021)
11.1.5 Seattle Children’s Recent Development
11.2 CureSearch
11.2.1 CureSearch Company Details
11.2.2 CureSearch Business Overview
11.2.3 CureSearch Neuroblastoma Treatment Introduction
11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2016-2021)
11.2.5 CureSearch Recent Development
11.3 Texas Children’s
11.3.1 Texas Children’s Company Details
11.3.2 Texas Children’s Business Overview
11.3.3 Texas Children’s Neuroblastoma Treatment Introduction
11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2016-2021)
11.3.5 Texas Children’s Recent Development
11.4 NANT
11.4.1 NANT Company Details
11.4.2 NANT Business Overview
11.4.3 NANT Neuroblastoma Treatment Introduction
11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2016-2021)
11.4.5 NANT Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Combination Chemotherapy
Table 3. Key Players of Monoclonal Antibody Therapy
Table 4. Key Players of Vaccine Therapy
Table 5. Key Players of Others
Table 6. Global Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Neuroblastoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Neuroblastoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Neuroblastoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Neuroblastoma Treatment Market Share by Regions (2022-2027)
Table 12. Neuroblastoma Treatment Market Trends
Table 13. Neuroblastoma Treatment Market Drivers
Table 14. Neuroblastoma Treatment Market Challenges
Table 15. Neuroblastoma Treatment Market Restraints
Table 16. Global Neuroblastoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Neuroblastoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Treatment as of 2020)
Table 19. Ranking of Global Top Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Neuroblastoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Neuroblastoma Treatment Product Solution and Service
Table 23. Date of Enter into Neuroblastoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Neuroblastoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Neuroblastoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Neuroblastoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Neuroblastoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Neuroblastoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Seattle Children’s Company Details
Table 64. Seattle Children’s Business Overview
Table 65. Seattle Children’s Neuroblastoma Treatment Product
Table 66. Seattle Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Seattle Children’s Recent Development
Table 68. CureSearch Company Details
Table 69. CureSearch Business Overview
Table 70. CureSearch Neuroblastoma Treatment Product
Table 71. CureSearch Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 72. CureSearch Recent Development
Table 73. Texas Children’s Company Details
Table 74. Texas Children’s Business Overview
Table 75. Texas Children’s Neuroblastoma Treatment Product
Table 76. Texas Children’s Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Texas Children’s Recent Development
Table 78. NANT Company Details
Table 79. NANT Business Overview
Table 80. NANT Neuroblastoma Treatment Product
Table 81. NANT Revenue in Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 82. NANT Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Combination Chemotherapy Features
Figure 3. Monoclonal Antibody Therapy Features
Figure 4. Vaccine Therapy Features
Figure 5. Others Features
Figure 6. Global Neuroblastoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Neuroblastoma Treatment Report Years Considered
Figure 11. Global Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Neuroblastoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Neuroblastoma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Neuroblastoma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Neuroblastoma Treatment Market Share by Players in 2020
Figure 16. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroblastoma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2020
Figure 18. Global Neuroblastoma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Neuroblastoma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 22. North America Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 23. North America Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 24. United States Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2016-2027)
Figure 40. China Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Seattle Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021)
Figure 60. CureSearch Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021)
Figure 61. Texas Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021)
Figure 62. NANT Revenue Growth Rate in Neuroblastoma Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の神経芽細胞腫治療市場 2021：企業別、地域別、種類・用途別 The Neuroblastoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界の小児神経芽細胞腫治療市場規模・現状・予測（2021年-2027年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…
- 世界の併用抗体療法市場規模・現状・予測（2021年-2027年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…
- 世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- 世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年） For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body. …